QNTM Quantum BioPharma Ltd.
Company Analysis
Latest News
🔴 Quantum BioPharma is trading 5% down today as Nasdaq Composite falls 0.65%
Quantum BioPharma is trading 5% down at $3.27 amid broader risk-off market pressure, with the Nasdaq Composite down 0.65% and elevated Treasury yields weighing...
🟢 Quantum BioPharma is trading 10.78% up today after positive Moderna and Merck Phase 3 melanoma-vaccine results
Quantum BioPharma is trading 10.78% up at $3.78 after a broad biotech-sector rally following positive Moderna and Merck Phase 3 melanoma-vaccine results. -...
🟢 Quantum BioPharma is trading 8.98% up today as positive Moderna trial results lift the biotech sector
Quantum BioPharma is trading at $3.64 (up 8.98%), gaining alongside a broader biotech sector rally triggered by positive Moderna cancer-vaccine trial results...
🔴 Quantum BioPharma is trading 10.05% down today as risk-off sentiment pressures speculative stocks
Quantum BioPharma is trading 10.05% down now at $3.31 as broader risk-off sentiment pressures speculative stocks. - The Nasdaq Composite is down 1.35%, while...
🔴 Quantum BioPharma is trading 9.78% down today amid apparent broader risk-off trading
Quantum BioPharma is trading at $3.33 (-9.78%) now, amid what appears to be broader risk-off trading. - August 17, 2026, second-quarter results showed...
🟢 Quantum BioPharma is trading 5.86% up in pre-market after Q2 results showed lower operating expenses
Quantum BioPharma is trading 5.86% up at $3.90 after its August 17, 2026 second-quarter update reported a 53% year-over-year reduction in operating expenses...
🔴 Quantum BioPharma is trading 6.51% down in pre-market as Nasdaq futures fall 1.19%
Quantum BioPharma is trading 6.51% down at $3.44, with the decline appearing consistent with broader risk-off conditions; no fresh company-specific negative...
🔴 Quantum BioPharma is trading 6.58% down today — decline remains unexplained
Quantum BioPharma is trading 6.58% down now at $3.55, with the decline remaining unexplained. - It opened August 17, 2026 below the August 14 close of $3.80;...
🟢 Quantum BioPharma is trading 12.61% up in pre-market after FDA approval for Lucid-MS Phase 2
Quantum BioPharma is trading at $4.28 (+12.61%) in pre-market after FDA approval of an IND allowing Lucid-MS to advance into Phase 2. - The randomized,...
🟢 Quantum BioPharma is trading 8.4% up in pre-market after FDA approval for Lucid-MS Phase 2
Quantum BioPharma is trading 8.43% up now at $4.12 after momentum continued from its August 14, 2026 Q2 results and FDA approval to advance Lucid-MS into a...
🟢 Quantum BioPharma Surges 11.46% After Strong Q2 Results and FDA Clearance for Lucid-MS Phase 2
Quantum BioPharma is trading at $3.60 (+11.46%) today, following the release of robust Q2 2026 financial results and the recent FDA clearance for Lucid-MS to...
🟢 Quantum BioPharma is trading 5% up today after Q2 results and stronger liquidity
Quantum BioPharma is trading 5.11% up now at $3.40 after reporting second-quarter 2026 results and stronger liquidity on August 14, 2026. - Reported...
🟢 Quantum BioPharma is trading 7.43% up in pre-market after a 7.18% prior-session decline
Quantum BioPharma is trading at $3.47 (+7.43%) in pre-market, rebounding after a 7.18% decline on August 13. - No fresh company-specific announcement was...
🔴 Quantum BioPharma is trading 10.34% down today with no fresh company-specific catalyst identified
Quantum BioPharma is trading 10.34% down at $3.12 with no fresh company-specific catalyst identified for August 13, 2026. - The latest major announcement was...
🔴 Quantum BioPharma is trading 6.49% down today — no fresh company-specific catalyst identified
Quantum BioPharma is trading 6.49% down at $3.25, despite broader U.S. markets moving higher on cooler inflation and easing interest-rate concerns; no fresh...
🔴 Quantum BioPharma is trading 7.18% down today in pre-market
Quantum BioPharma is trading at $3.23, down 7.18%, after no fresh company-specific catalyst was identified for August 13, 2026. • The recent FDA clearance for...
🔴 Quantum BioPharma is trading 5% down in after-hours trading with no fresh company-specific catalyst identified
Quantum BioPharma is trading 5.17% down now at $3.30 in after-hours trading, with no fresh August 12 company-specific announcement or earnings release...
🟢 Quantum BioPharma is trading 5% up today after FDA approval moved Lucid-MS into Phase 2
Quantum BioPharma is trading at $3.64 (+5.20%) after the FDA approved its Investigational New Drug application for Lucid-MS on August 10, 2026, allowing the...
🟢 Quantum BioPharma is trading 8.38% up in pre-market after FDA cleared Lucid-MS for Phase 2 development
Quantum BioPharma is trading 8.38% up at $3.75 after the FDA approved its Investigational New Drug application for Lucid-MS on August 10, 2026, allowing the...
🟢 Quantum BioPharma is trading 12.75% up today after FDA cleared Lucid-MS IND for Phase 2 trial
Quantum BioPharma is trading 12.75% up now at $3.89 after the FDA cleared its Investigational New Drug application for Lucid-MS, enabling a Phase 2 trial for...